Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Cutan Pathol ; 48(7): 863-869, 2021 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-33486806

RESUMO

BACKGROUND: Pyogenic granuloma (PG) is a lesion characterized by the proliferation of blood vessels, commonly affecting the skin and the mouth. We aimed to compare clinical, microscopic, and immunohistochemical features of the two types of oral PG: lobular capillary hemangioma (LCH) and non-LCH (NLCH). METHODS: Epidemiological and clinical data from 2000 to 2018 were collected from the archives of our institution, and histopathological sections of PG were reviewed. Immunohistochemical analyses (CD34, D2-40, SMA, mast cell, and Ki-67) were performed in 34 cases. RESULTS: Sixty-two LCH and 107 non-LCH samples were included. The mean (±SD) age of the patients was 38.59 ± 16.96 years; 55.62% were female; 39.64% of cases occurred in the gingiva, 44% of the nodules were pedunculated, and 13.02% of patients reported a history of trauma. NLCH was more prevalent among older patients than LCH. The most prevalent site of LCH was the lips, while NLCH occurred more in the gingiva (P < 0.05). Epithelial atrophy, microvessels, SMA-positive areas, and Ki-67-positive nuclei were more prevalent in LCH (P < 0.05). CONCLUSIONS: PG accounted for 2.25% of lesions archived in the pathology service and most cases were NLCH. LCH and NLCH exhibited clinicopathological differences in terms of age, site, epithelial atrophy, vascularization, and proliferation rate.


Assuntos
Granuloma Piogênico/diagnóstico , Granuloma Piogênico/metabolismo , Mucosa Bucal/patologia , Neovascularização Patológica/patologia , Actinas/metabolismo , Adulto , Biópsia , Estudos de Casos e Controles , Feminino , Gengiva/patologia , Granuloma Piogênico/epidemiologia , Granuloma Piogênico/patologia , Humanos , Imuno-Histoquímica/métodos , Antígeno Ki-67/metabolismo , Lábio/patologia , Masculino , Pessoa de Meia-Idade , Boca/patologia , Mucosa Bucal/irrigação sanguínea , Mucosa Bucal/ultraestrutura , Prevalência , Estudos Retrospectivos
2.
Arch Oral Biol ; 119: 104894, 2020 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-32950917

RESUMO

OBJECTIVE: Lactobacillus reuteri is reported as a beneficial adjunct to conventional periodontitis treatment or as monotherapy for gingivitis in several clinical trials. However, probiotics are not free from the risk of adverse effects. We investigated the effects of live and heat-killed (paraprobiotic) L. reuteri during the development of ligature-induced periodontitis in rats. METHODS: Thirty-two male rats were divided into four groups-control group: healthy rats, LIP group: rats with ligature induced periodontitis, LIP/PRO group: rats with periodontitis that received live L. reuteri, LIP/PARA group: rats with periodontitis that received heat-killed L. reuteri. Treatment was administered for 30 days prior to ligation and continued for 14 days until euthanasia. The hemimandibles were removed and submitted to radiographic analysis, microcomputerized microtomography (µCT) and histomorphometric analysis. RESULTS: Radiographic analysis revealed that pro- and paraprobiotics enhanced the percentage of mesial bone support. The µCT analysis showed that paraprobiotic treatment increased bone volume and trabecular number while decreasing total bone porosity and trabecular separation. Live probiotic led to higher trabecular thickness. In the histomorphometric analysis, paraprobiotics significantly prevented furcation bone loss and collagen breakdown, although both pro- and paraprobiotics similarly reduced mesial bone loss. There were no significant differences in attachment loss or the number of tartrate-resistant acid phosphatase -positive cells across treatments. CONCLUSIONS: Although viable and heat-killed bacteria reduced mesial alveolar bone loss and ameliorated furcation microarchitecture parameters, paraprobiotics presented the most pronounced results preventing periodontitis development. This can contribute to the future use of paraprobiotics in the prevention and treatment of periodontitis.


Assuntos
Perda do Osso Alveolar , Limosilactobacillus reuteri , Periodontite , Probióticos/uso terapêutico , Perda do Osso Alveolar/prevenção & controle , Animais , Temperatura Alta , Masculino , Periodontite/prevenção & controle , Ratos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA